Healthcare Business Review
About Us Conference Advertise With Us
  • Patient Care
    Medical Transportation
    Plastic Surgery
    Regenerative Medicine
    Therapy Services 
  • Operations
    Consulting Service
    Digital Transformation
    healthcare Insurance
    Healthcare Marketing
    Healthcare Outsourcing
    Healthcare Staffing
    Medical Billing
    Medical Staff Training and Development
  • Healthcare Services
    Facility Management Services
    Healthcare Education
    Healthcare Procurement
  • Leadership Perspectives
  • Insights
  • News
  • Magazines
  • CXO Awards
    • APAC
      • US
      • EUROPE
      • APAC
      • CANADA
      • LATAM
×
#

Healthcare Business Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Healthcare Business Review

Subscribe

loading

Thank you for Subscribing to Healthcare Business Review Weekly Brief

  • Home
  • News

APAC Insurers & Employers Discuss Cost Risk Associated with Regenerative Medicine

By

Healthcare Business Review | Thursday, June 11, 2026

APAC insurers and employers are currently dealing with a new challenge related to how they reimburse regenerative medicines that are increasingly close to being used in clinical practice. Regenerative medicine represents certain risks associated with the treatment itself and the reimbursement framework for it, which is currently under discussion.


The topic appears due to the growth of advanced therapies on the market of Asia-Pacific, making the private insurance sector consider whether it is possible to pay for therapies that offer a long-term medical potential but have high initial costs and unclear coverage standards.

Stay ahead of the industry with exclusive feature stories on the top companies, expert insights and the latest news delivered straight to your inbox. Subscribe today.


Insurance companies in Asia-Pacific need to figure out how to classify regenerative medicines as either experimental care, specialty treatment or medically necessary intervention. The classification issue has been complicated since such treatment does not always fit traditional approaches to medication reimbursement. The issue involves additional laboratory services, extended monitoring or personalized manufacturing processes that cannot be assessed with a current code system.


Employers' interest in the issue is driven by their existing problems with healthcare funding. The increased healthcare costs put pressure on employee benefits, which means that there may arise differences between healthcare provision standards in countries where a company operates.


Insurers may also be concerned about long-term evidence development and the ability to evaluate a treatment's effectiveness properly. Some regenerative medicine offers a reduction in the disease burden in the long run, but there might be no easy way to measure its effectiveness or make a cost-benefit analysis at an early stage.


Public awareness about regenerative medicine also contributes to the discussion as patients can have misconceptions about coverage standards when dealing with such medicines at special clinics or via medical tourism. Therefore, it is important for insurers to introduce new mechanisms to reduce the risk of covering unnecessary therapies for employers.


In some cases, such mechanisms are implemented through narrower pathways for coverage or specific case assessments of regenerative medicines. While it helps to avoid risks for a while, it can lead to difficulties for healthcare providers that have trouble adjusting to the complex process of treatment provision.


Employers, who rely heavily on a highly skilled workforce, are interested in the reimbursement issue, particularly, those therapies that are used to recover from orthopedic conditions, degenerative diseases and cancers. However, workforce retention issues do not guarantee that finance specialists will have an easy time estimating the future costs of such treatments, given their unstable price pattern.


Regenerative medicine is also discussed in terms of growing healthcare inequalities as such advanced therapies may become accessible only to private healthcare and major urban centers if reimbursement standards develop unevenly in APAC. Such development can cause difficulties for smaller employers and public systems with little or no reimbursement frameworks and pricing strategies developed.


More in News

The Growing Impact of Mobile Phlebotomy on Healthcare Delivery

Mobile phlebotomy services are expanding as healthcare systems focus on convenience, accessibility, and patient-centered diagnostics. Its shift reflects a broader trend in healthcare delivery, where services are brought closer to patients rather than requiring them to travel. The growing demand for chronic disease monitoring, preventive testing, and post-discharge care has made mobile phlebotomy an essential part of modern diagnostic processes. Why Is Mobile Phlebotomy Demand Rising Across Care Settings? Rising demand for mobile phlebotomy stems largely from changing patient expectations and care models. Patients increasingly value services that fit into daily routines, especially those managing chronic conditions requiring frequent testing. Home-based blood collection eliminates travel stress and waiting times, making routine diagnostics more manageable. Healthcare providers also benefit from this approach. Mobile phlebotomy supports hospital-at-home programs, post-surgical follow-ups, and remote patient monitoring initiatives. Compass Health Consultants helps healthcare providers optimize these programs by streamlining sample collection and integrating digital tools to ensure better patient tracking. Reliable sample collection outside traditional facilities helps clinicians track patient progress without unnecessary readmissions or clinic visits. This flexibility strengthens care coordination and improves outcomes. Aging populations further accelerate adoption. Older adults often require regular laboratory testing, but may face challenges visiting diagnostic centers. Mobile services provide a safer and more comfortable alternative, particularly for individuals with limited mobility or compromised immunity. Long-term care facilities also rely on mobile phlebotomy to reduce disruptions and maintain infection control standards. Employer-sponsored health programs contribute to demand growth as well. Workplace testing initiatives use mobile phlebotomy to support wellness screenings, occupational health compliance, and preventive care. These services minimize productivity loss while expanding access to essential Statewise specializes in developing AI-driven healthcare technologies that enhance mobile phlebotomy workflows, improving accuracy and efficiency in patient diagnostics.diagnostics. How are technology and workforce models transforming service delivery? Technology plays a central role in improving mobile phlebotomy efficiency and reliability. Digital scheduling platforms allow patients, providers, and laboratories to coordinate appointments seamlessly. Automated reminders and real-time updates reduce no-shows and optimize route planning for phlebotomists. Electronic health record integration strengthens data accuracy and turnaround times. Secure digital transmission of orders and results reduces administrative burden and supports faster clinical decision-making. These tools also enhance traceability, ensuring proper sample handling from collection to laboratory processing. Workforce strategies evolve alongside technology. Mobile phlebotomy providers invest in specialized training focused on patient communication, home-based safety protocols, and diverse collection environments. Skilled phlebotomists adapt techniques to accommodate varying conditions while maintaining sample integrity and patient comfort. Quality assurance remains a priority as services scale. Standardized procedures, temperature-controlled transport, and compliance monitoring ensure diagnostic accuracy regardless of collection location. Providers emphasize consistency to maintain trust among laboratories, clinicians, and patients.   ...Read more

Referral Coordination Remains a Practical Question for Multidisciplinary Pain Clinics

A person living with chronic pain rarely interacts with a single healthcare professional. The path often moves between physicians, rehabilitation providers and other specialists over an extended period. That reality helps explain why multidisciplinary chronic pain and injury clinics continue to attract attention across Canada. The concept is straightforward. Patients living with ongoing pain often need support from more than one part of the care team. They may be working through physical rehabilitation while also being assessed by a physician. What happens in one part of their care can affect the decisions being made in another. When those conversations happen in separate places, updates can take longer to reach the right people, and important details can be lost along the way. This is one reason referral coordination remains a recurring discussion around multidisciplinary clinics. The value is not limited to the services offered. It also relates to how information travels between people involved in the patient's care. Complex cases rarely end with the clinical appointment. Once the assessment is done, another layer of work begins. Reports have to be read properly, recommendations need to reach the people who can act on them, and every follow-up adds another set of notes, updates and records. That work does not treat the pain itself, but it often decides whether the next step in care moves cleanly or gets held up. This is one reason multidisciplinary clinics matter. They do not make difficult cases simple. Doctors may still disagree, and judgment will still depend on the patient in front of them. But when different specialists are working closer together, the conversation is easier to keep in one place instead of being scattered across separate offices, referrals and delays. For insurers, employers and legal stakeholders connected to injury cases, communication can become almost as important as treatment itself. Questions about recovery status, functional limitations and future care plans often depend on information coming from several sources. The more people involved, the greater the need for consistent documentation. That creates an administrative consideration that extends beyond patient care. Clinics are not only managing appointments and assessments. They are also managing information flow among parties who may be relying on the same case file for different purposes. The difficulty is that better coordination is not effortless. Once more people are involved in a case, there is often more to check, discuss and agree on before anything moves forward. That can improve the quality of the decision, but it can also slow the pace of care. Clinics have to find a way to get the benefit of shared judgment without turning every step into another hold-up. Interest in multidisciplinary care is unlikely to rest solely on treatment philosophy. Day-to-day coordination remains part of the conversation. How clinics handle communication, documentation and case management may continue to shape perceptions of their effectiveness just as much as the clinical services themselves. ...Read more

Workforce Pressures Could Shape How Multidisciplinary Care Is Delivered

Finding the right mix of expertise has always been part of running a multidisciplinary chronic pain and injury clinic. The model depends on bringing together professionals whose roles may overlap at certain points while remaining distinct in others. That sounds manageable in theory. In practice, scheduling alone can become complicated when several providers contribute to the same patient journey. Chronic pain cases often develop over long periods. Patients may arrive with extensive medical histories, previous treatments and questions that do not fit neatly into a single appointment. The work requires time and attention. It also requires professionals who are comfortable operating within a shared care environment. The challenge is not just finding people to fill open roles. Clinics need providers who bring real expertise to the table, but who can also work inside a larger treatment plan. One clinician may be focused on a specific part of recovery, but their decisions often depend on what others are seeing elsewhere in the patient’s care. That changes what workforce strength looks like. Clinical skill still matters, but it is not enough on its own. Providers also need to communicate clearly, understand the wider case picture and recognize how their recommendations sit alongside the judgment of other professionals involved in the same patient’s treatment. Hiring, then, is only part of the issue. Keeping staff matters just as much. When patients stay in treatment over longer periods, continuity can shape how well their cases are managed. Frequent turnover adds more handoffs, more adjustment and more time spent getting new providers up to speed. Knowledge transfer can become another consideration. Experienced practitioners often develop an understanding of recurring case patterns through years of practice. Some of that knowledge appears in documentation. Some of it comes from direct experience with patients, referral sources and clinical workflows. Multidisciplinary clinics are not the only healthcare settings dealing with these pressures. Staffing challenges are being felt across the system. But clinics built around collaboration can feel those changes more sharply because care often depends on several professionals working through the same treatment plan. Patients do not usually see that in terms of staffing structures. They feel it in more practical ways: how soon they can get an appointment, whether the same people remain involved in their care and whether important details carry over from one visit to the next. For multidisciplinary pain clinics in Canada, workforce issues are unlikely to move into the background anytime soon. Conversations about care models often focus on treatment methods, but those models only work if there are enough trained people available to deliver them consistently. ...Read more

Expectations Around Recovery Can Be Difficult to Manage in Chronic Pain Care

One of the less discussed aspects of chronic pain treatment involves expectations. Patients often arrive at a clinic hoping for clear answers after spending months or even years searching for relief. Multidisciplinary care can broaden the range of expertise available, but it does not necessarily make recovery straightforward. This creates a communication challenge for clinics. Pain is rarely experienced in the same way by every patient. Two individuals with similar injuries may describe very different outcomes. Progress can be uneven. Treatment plans may change over time as new information becomes available. That uncertainty is present from the first appointment. Patients want to know what improvement might look like, how long it could take and whether the treatment is likely to help. Clinics have to answer those questions carefully. They need to offer enough reassurance to keep patients engaged, without making recovery sound more predictable than it really is. The conversation becomes more complicated in injury-related cases where employers, insurers or legal representatives are also involved. Each party may be looking at the same case through a different lens. One may be focused on whether the patient can return to work. Another may be tracking treatment progress. A third may need clear documentation to support a claim or decision. Multidisciplinary clinics are often caught in the middle of these expectations. A patient’s care may involve several professionals, and that broader perspective can be useful when everyone understands the same goals. Problems arise when expectations move faster than the patient’s actual clinical progress. Much of this comes down to communication. Formal reports matter, but so do the smaller conversations that happen during appointments. A treatment plan can be clinically sound, yet still leave a patient unsure if no one has clearly explained what to expect, what may change slowly and why the plan is being adjusted. That is especially important in chronic pain care, where improvement is rarely tied to one clear endpoint. Progress may come gradually. It may show up in better movement, higher activity levels or small changes in daily life rather than a complete resolution of pain. For clinics, this makes patient engagement a central part of care. When patients understand why a recommendation has been made, they are more likely to stay with the treatment plan. When they are confused, uncertain or expecting faster results, participation can weaken even when the clinical reasoning is still sound. Multidisciplinary clinics are often evaluated through the lens of treatment options and specialist access. Those factors matter, but they are only part of the story. Managing expectations, explaining progress and maintaining trust throughout a long treatment journey remain central parts of the work. Those conversations may never attract the same attention as clinical interventions, yet they often shape how patients experience care from beginning to end. ...Read more
Copyright © 2026 Healthcare Business Review. All rights reserved. |  Subscribe |  Sitemap |  About us |  Newsletter |  Feedback Policy |  Editorial Policy follow on linkedin
CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.healthcarebusinessreviewapac.com/news/apac-insurers-employers-discuss-cost-risk-associated-with-regenerative-medicine-nwid-3301.html